Home › Alzheimer's Disease › New York › Staten Island
Alzheimer's Disease clinical trials in Staten Island, NY
4 studies for Alzheimer's Disease are looking for participants at sites in and around Staten Island (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
RecruitingPhase 3
- Local Institution - 2619, Staten Island
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
RecruitingPhase 3
- Richmond Behavioral Associates, Staten Island
Trial-Ready Cohort-Down Syndrome (TRC-DS)
RecruitingObservational study
- New York State Institute for Basic Research in Developmental Disabilities (SIBRDD), Co-Enrolling through ABC-DS Only, Staten Island
Open-label Extension Study in Participants With Early Alzheimer's Disease
RecruitingPhase 2
- GSK Investigational Site, Staten Island
About Alzheimer's Disease
Alzheimer's disease is a brain disorder that slowly destroys memory and thinking skills. It's the most common cause of dementia among older adults.
More about Alzheimer's Disease on MedlinePlus
Alzheimer's Disease trials in other cities
- Boston, MA26 studies
- Orlando, FL25 studies
- St. Louis, MO22 studies
- New York City, NY21 studies
- Miami, FL20 studies
- Tampa, FL17 studies
- Atlanta, GA16 studies
- The Villages, FL15 studies
- Philadelphia, PA15 studies
- Phoenix, AZ15 studies
- Indianapolis, IN14 studies
- Los Angeles, CA14 studies
Other studies in Staten Island
- Breast Cancer40 studies
- Non-Small Cell Lung Cancer19 studies
- Prostate Cancer16 studies
- Acute Myeloid Leukemia14 studies
- Multiple Myeloma13 studies
- Lung Cancer12 studies
- Bladder Cancer11 studies
- Cancer (all types)11 studies
- Endometrial Cancer11 studies
- Metastatic Cancer10 studies
- Ovarian Cancer9 studies
- Head and Neck Squamous Cell Carcinoma9 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.